Search for a trial

1 results

Phase I, open-label, 3-way crossover trial in healthy male subjects to
evaluate the pharmacokinetics of TMC114 and TMC41629 after a
single oral dose of 2 controlled-release coformulations as compared to
an immediate-release coformulation of TMC114/TMC41629

Approved WMORecruitment stopped

This is a scientific research with the aim to investigate the bioavailability of a combination of the drugs TMC114 and TMC41629 . The three dosage forms, each only once ingested. In addition, even in this study the safety of the use and possible…

Phase I, open-label, 3-way crossover trial in healthy male subjects to evaluate the pharmacokinetics of TMC114 and TMC41629 after a single oral dose of 2 controlled-release coformulations as compared to an immediate-release coformulation of TMC114/TMC41629

Phase I, open-label, 3-way crossover trial in healthy male subjects to
evaluate the pharmacokinetics of TMC114 and TMC41629 after a
single oral dose of 2 controlled-release coformulations as compared to
an immediate-release coformulation of TMC114/TMC41629